How Eliminating P2P Friction Helps Pharmaceutical, Biotechnology, and Medical Device Firms Manage Cash

Pharmaceutical, biotechnology, and medical device manufacturing firms are facing legislative uncertainty, mounting regulatory pressure, volatile economic conditions. It is for these reasons that more firms in this space are automating their Procure-to-Pay (P2P) processes.

Eliminating friction in the P2P cycle with technologies such as electronic invoicing helps pharmaceutical, biotechnology, and medical device manufacturing firms:

• Improve profit margins
• Enhance visibility into cash flow
• Lower their cost of goods

Best of all: P2P automation delivers these benefits, regardless of the legislative, regulatory and business conditions. IOFM’s latest white paper details the findings from a survey of P2P professionals at pharmaceutical, biotechnology, and medical device manufacturing firms. The white paper reveals:

• Key P2P benchmarking data
• The primary causes of friction in the P2P cycle
• The top P2P objectives of pharmaceutical firms

Don’t risk falling behind your peers in the pharmaceutical, biotechnology, and medical device manufacturing space. Claim your copy of IOFM’s white paper today!

Continuing Education Credits available:

Receive 1 CEU toward renewing APM, APS, APPM or APPS certification from the Institute of Finance and Management! The Accounts Payable Certification and Procure-to-Pay Certification Programs are designed to establish standards for the profession and recognize Accounts Payable and Procure-to-Pay professionals who, by possessing related work experience and passing a comprehensive exam, have met stringent requirements for mastering the Accounts Payable and Procure-to-Pay bodies of knowledge

This white paper is provided free of charge and underwritten by a sponsor. Following your download, you may be contacted by the sponsor with information about their products and services.